Read more

December 06, 2019
1 min read
Save

Top stories in gastroenterology: Low-volume bowel prep, peroral endoscopic myotomy, and more

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The results of a new metanalysis that compared low-volume, split-dose bowel preparations and high-volume preparations was the top story in gastroenterology last week, followed by the findings of a new study that examined how well peroral endoscopic myotomy performed in patients with achalasia.

Learn more about the top stories in gastroenterology below.

Low-volume bowel prep still effective, but better tolerated

Low-volume, split-dose bowel preparations were just as effective as high-volume preps with the added benefit of being better tolerated by patients, according to the results of a metanalysis. Read more.

Peroral endoscopic myotomy more effective than previous estimates for achalasia

Peroral endoscopic myotomy is highly safe and effective for at least 1 year for the treatment of achalasia and outperformed previous efficacy estimates, according to study results. Read more.

Complete endoscopic healing linked with better Crohn’s outcomes

Patients with Crohn’s disease who achieved complete mucosal healing experienced better outcomes than those who just had partial healing, according to study results. Read more.

When physicians get screened for colorectal cancer, so do their patients

Individuals are more likely to participate in colorectal cancer screening if their family physician has undergone screening, according to study results. Read more.

Gastric electrical stimulation reduces frequency of refractory vomiting

Patients with refractory vomiting who received gastric electrical stimulation therapy experienced a reduction in the frequency of vomiting episodes, according to study results. Read more.